Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855412 · ClinicalTrials.gov registry record
Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,204
- Enrollment target
NCT01855412 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,204 participants.
The verdict
NCT01855412 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,204 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
Interventions
- OTHER PAD endovascular treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,204 participants |
| Start Date | 2013-05 |
| Est. Completion | 2019-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01855412
The ClinicalTrials.gov registry entry for NCT01855412 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PAD endovascular treatments is the first listed.
NCT01855412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01855412 about?
NCT01855412 is a clinical study titled "Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes". The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
What is the current status of trial NCT01855412?
This trial is currently completed. The enrollment target is 1,204 participants. The study started on 2013-05. Estimated completion is 2019-04-11.
What interventions are being tested in trial NCT01855412?
The interventions under investigation include: PAD endovascular treatments (OTHER).
Who is sponsoring clinical trial NCT01855412?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.